A major study presented at the RSNA reveals that invasive breast cancer is more common in younger women than previously assumed, underscoring the need to revisit current screening and risk-assessment strategies.
A session highlighting how amyloid, tau, and FDG PET sharpen Alzheimer’s diagnosis, support therapy decisions, and improve safety monitoring, marking a key advance in precision imaging.
Medimaps Group has introduced TBS Reveal, an AI-powered screening software that analyzes routine X-rays to assess bone fragility by evaluating bone microarchitecture and bone mass.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.